Hyperuricemia, characterized by elevated serum uric acid levels, has been increasingly recognized as a potential risk factor for the development of T2DM, underscoring the need for a deeper understanding of its pathophysiological impact on glucose metabolism and insulin sensitivity (1, 2). This evidence concerns the gene INS and hyperuricemia.